Peer-reviewed studies on EIT in ventilation—covering validation, therapies, personalized care, weaning, delivery room use, and guidelines.

Explore how transcutaneous CO₂ monitoring delivers noninvasive, real-time insights to support better outcomes for both clinicians and patients.

Ella lives with nemaline myopathy, a rare genetic disorder affecting approximately 1 in 50,000 births. This condition weakens the skeletal muscles responsible for movement, making everyday tasks like walking, speaking, swallowing, and even breathing uniquely challenging.

The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations.

The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations. This brochure provides healthcare professionals with an understanding of the clinical utility and benefits of IPV therapy as demonstrated in the available evidence.

By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.

Transcutaneous CO2 monitoring (tcPCO2) is considered by many neonatal teams to be standard of care in the NICU for intubated patients – but many children’s hospitals utilize this technology across many more patient types and care settings. This document explores tcPCO2 in clinical settings, demonstrating the impact that this technology can have throughout a children’s hospital.

With a full suite of devices, IPV therapy is designed to support a wide range of patients facing these respiratory challenges — providing seamless care from hospital to home.

IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.

The Sentec suite of attachment options for transcutaneous CO2 monitoring allows care teams to confidently choose solutions that support the clinical priorities of each patient — across populations and care settings.